A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Beijing Biotech
Corvus Pharmaceuticals, Inc.
Seagen Inc.
Bristol-Myers Squibb
SecuraBio
Pfizer
Karyopharm Therapeutics Inc
Bristol-Myers Squibb
Taiho Oncology, Inc.
Seagen Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
Haihe Biopharma Co., Ltd.
Haihe Biopharma Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Seagen Inc.
Aileron Therapeutics, Inc.
Evopoint Biosciences Inc.
Antengene Corporation
Dizal Pharmaceuticals
CellCentric Ltd.
Daiichi Sankyo
Dizal Pharmaceuticals
Acrotech Biopharma Inc.
Treeline Biosciences, Inc.
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Chipscreen Biosciences, Ltd.
Boryung Pharmaceutical Co., Ltd
Affimed GmbH
Boston Immune Technologies and Therapeutics
Dizal Pharmaceuticals
Kura Oncology, Inc.
Bristol-Myers Squibb
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Dizal Pharmaceuticals
Kymera Therapeutics, Inc.
Great Novel Therapeutics Biotech & Medicals Corporation
SecuraBio
Bio-Path Holdings, Inc.
Seagen Inc.
Daiichi Sankyo
Genfleet Therapeutics (Shanghai) Inc.
Evopoint Biosciences Inc.
Nanjing Zenshine Pharmaceuticals
Affimed GmbH
BeiGene
Takeda
HUYABIO International, LLC.
Taiho Oncology, Inc.